Quintet Private Bank Europe S.A. boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.2% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 87,554 shares of the healthcare conglomerate's stock after buying an additional 2,722 shares during the quarter. UnitedHealth Group makes up about 2.7% of Quintet Private Bank Europe S.A.'s holdings, making the stock its 8th biggest position. Quintet Private Bank Europe S.A.'s holdings in UnitedHealth Group were worth $45,856,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. NewSquare Capital LLC purchased a new stake in UnitedHealth Group in the 4th quarter worth approximately $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in shares of UnitedHealth Group during the 4th quarter valued at $26,000. Hurley Capital LLC bought a new position in shares of UnitedHealth Group during the 4th quarter valued at $28,000. Aster Capital Management DIFC Ltd bought a new position in shares of UnitedHealth Group during the 4th quarter valued at $30,000. Finally, Promus Capital LLC bought a new position in shares of UnitedHealth Group during the 4th quarter valued at $32,000. Hedge funds and other institutional investors own 87.86% of the company's stock.
UnitedHealth Group Trading Down 1.6%
Shares of UNH traded down $5.11 on Friday, reaching $313.39. 13,729,200 shares of the company's stock were exchanged, compared to its average volume of 7,185,786. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $284.28 billion, a P/E ratio of 20.22, a price-to-earnings-growth ratio of 1.37 and a beta of 0.45. The business has a 50 day moving average price of $386.66 and a two-hundred day moving average price of $474.19. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the prior year, the firm posted $6.91 EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be issued a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.82%. The ex-dividend date is Monday, June 16th. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio is 37.02%.
Insider Activity
In related news, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer now owns 10,398 shares in the company, valued at approximately $3,171,390. This represents a 5.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director John H. Noseworthy bought 300 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 14th. The shares were acquired at an average price of $312.16 per share, with a total value of $93,648.00. Following the acquisition, the director now directly owns 6,063 shares of the company's stock, valued at $1,892,626.08. The trade was a 5.21% increase in their position. The disclosure for this purchase can be found here. Insiders purchased 109,408 shares of company stock worth $31,607,768 over the last quarter. 0.28% of the stock is currently owned by company insiders.
Analyst Ratings Changes
UNH has been the topic of a number of recent research reports. Piper Sandler cut their price target on shares of UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating on the stock in a report on Tuesday, June 3rd. Robert W. Baird lowered shares of UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 target price on the stock. in a research note on Wednesday. Hsbc Global Res lowered shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. HSBC reiterated a "reduce" rating and issued a $270.00 target price (down from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Finally, Baird R W lowered shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of "Moderate Buy" and a consensus price target of $426.52.
View Our Latest Report on UNH
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.